Get started
Author

Lotte Hiddingh

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
2020 · Matthew Clarke, Alan Mackay, et al. · Cancer Discovery · 272
Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice
2013 · Yunching Chen, Yuhui Huang, et al. · Hepatology · 211
PDF
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2 -amplified breast cancer brain metastases
2012 · David P. Kodack, Euiheon Chung, et al. · Proceedings of the National Academy of Sciences · 152
Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs
2013 · Bakhos A. Tannous, Mariam Kerami, et al. · JNCI Journal of the National Cancer Institute · 131
PDF
WEE1 Kinase Inhibition Enhances the Radiation Response of Diffuse Intrinsic Pontine Gliomas
2012 · Viola Caretti, Lotte Hiddingh, et al. · Molecular Cancer Therapeutics · 75
Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition
2012 · Dinja Oosterhoff, Sinéad Lougheed, et al. · OncoImmunology · 63
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
2013 · Lotte Hiddingh, Bakhos A. Tannous, et al. · Oncotarget · 53
PDF
Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype
2017 · Jian Teng, Seyedali Hejazi, et al. · Neuro-Oncology · 37
Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis
2014 · Lotte Hiddingh, Rajiv S. Raktoe, et al. · Scientific Reports · 35
PDF
A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer
2016 · Tonny Lagerweij, Lotte Hiddingh, et al. · Oncotarget · 22
PDF
Hgg-25. Infant Gliomas Comprise Multiple Biological and Clinicopathological Subgroups
2018 · Matthew T Clarke, David TW Jones, et al. · Neuro-Oncology · 2
Abstract P3-12-03: Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases.
2012 · DP Kodack, E Chung, et al. · Cancer Research · 1
-omics and Prognostic Markers
2011 · F. Moriera, K. So, et al. · Neuro-Oncology · 1
PDF
Supplementary Data from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
2023 · Matthew Clarke, Alan Mackay, et al.
Supplementary Table S2 from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
2023 · Matthew Clarke, Alan Mackay, et al.
Supplementary Table S1 from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
2023 · Matthew Clarke, Alan Mackay, et al.
Data from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
2023 · Matthew Clarke, Alan Mackay, et al.
Supplementary Table S6 from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
2023 · Matthew Clarke, Alan Mackay, et al.
Supplementary Table S4 from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
2023 · Matthew Clarke, Alan Mackay, et al.
Supplementary Table S3 from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
2023 · Matthew Clarke, Alan Mackay, et al.
Supplementary Table S5 from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
2023 · Matthew Clarke, Alan Mackay, et al.
Supplementary Data from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
2023 · Matthew Clarke, Alan Mackay, et al.
PDF
Supplementary Table S7 from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
2023 · Matthew Clarke, Alan Mackay, et al.
Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype
2020 · Jian Teng, Seyedali Hejazi, et al. · Neuro-Oncology
PDF
Dipg-22. Identification of Therapeutic Targets in Dipgs Using Large-scale Rnai Screening
2017 · Kathrin Schramm, Murat Iskar, et al. · Neuro-Oncology
Works count: 32
Citation count: 1,055
H-index: 10
I10-index: 10
Year
Topic
Type